- Who can participate: Participants aged 18 to 65 who experience frequent migraines and have not responded to standard treatments may be eligible for this study.
- Study details: Participants will be randomly assigned to receive either the investigational treatment or a placebo. They will be required to attend regular clinic visits for monitoring and assessment of treatment effects.

